0001333277-19-000044.txt : 20190924 0001333277-19-000044.hdr.sgml : 20190924 20190924085610 ACCESSION NUMBER: 0001333277-19-000044 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190920 FILED AS OF DATE: 20190924 DATE AS OF CHANGE: 20190924 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shah Sujal CENTRAL INDEX KEY: 0001588861 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36500 FILM NUMBER: 191109316 MAIL ADDRESS: STREET 1: C/O CYMABAY THERAPEUTICS, INC. STREET 2: 7575 GATEWAY BLVD., SUITE 110 CITY: NEWARK STATE: CA ZIP: 94560 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc. CENTRAL INDEX KEY: 0001042074 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943103561 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7575 GATEWAY BOULEVARD STREET 2: SUITE 110 CITY: NEWARK STATE: CA ZIP: 94560 BUSINESS PHONE: 510-293-8800 MAIL ADDRESS: STREET 1: 7575 GATEWAY BOULEVARD STREET 2: SUITE 110 CITY: NEWARK STATE: CA ZIP: 94560 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX, INC. DATE OF NAME CHANGE: 20090721 FORMER COMPANY: FORMER CONFORMED NAME: METABOLEX INC DATE OF NAME CHANGE: 19970710 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2019-09-20 0001042074 CymaBay Therapeutics, Inc. CBAY 0001588861 Shah Sujal C/O CYMABAY THERAPEUTICS, INC. 7575 GATEWAY BOULEVARD, SUITE 110 NEWARK CA 94560 1 1 0 0 Chief Executive Officer Common Stock 2019-09-20 4 P 0 1900 5.50 A 111900 D Common Stock 2019-09-23 4 P 0 3100 5.55 A 115000 D /s/ Sujal Shah 2019-09-23